FTRE — Fortrea Holdings Inc. Stock Price, Chart & AI Report

Negative Dec 12, 2025 • 19:37 UTC GlobeNewswire Inc. • Grabar Law Office

Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Fortrea Holdings, Inc. (NASDAQ: FTRE); Synopsys, Inc. (NASDAQ: SNPS); and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar Law Office Investigates Claims on Your Behalf

Grabar Law Office is investigating potential securities fraud and fiduciary breaches for several publicly traded companies, alleging misleading statements and undisclosed business risks that potentially harmed shareholders.

CYTK FTRE SNPS WBTN securities fraud shareholder investigation fiduciary duties class action lawsuit

Sentiment note

Allegations of overstating revenue projections, cost savings, and business prospects following Labcorp spinoff

Neutral Dec 10, 2025 • 23:00 UTC GlobeNewswire Inc. • Fortrea

Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Fortrea announced granting 245,000 restricted stock units (RSUs) to two newly hired employees, with vesting occurring in three equal annual installments starting December 10, 2026.

FTRE RSUs inducement award stock units employee compensation

Sentiment note

The announcement is a standard corporate action of granting RSUs to new employees, indicating normal business operations without significant positive or negative implications

Negative Dec 2, 2025 • 17:39 UTC GlobeNewswire Inc. • Joshua H. Grabar

Important Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Fortrea Holdings, Inc. (NASDAQ: FTRE); Unicycive Therapeutics, Inc. (NASDAQ: UNCY); and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar Law Office is Investigating Claims on Your Behalf

Grabar Law Office is investigating potential securities fraud and fiduciary duty breaches for several publicly traded companies, alleging misleading statements and incomplete disclosures that potentially harmed shareholders.

CYTK FTRE UNCY WBTN securities fraud shareholder investigation fiduciary duty class action lawsuit

Sentiment note

Allegations of overstating revenue projections, cost savings, and business prospects post-spin-off

Positive Nov 24, 2025 • 12:00 UTC GlobeNewswire Inc. • Fortrea

Fortrea Completes $75.7 Million Senior Notes Tender Offer Utilizing Cash on Hand

Fortrea has completed a debt tender offer, purchasing $75.7 million of its outstanding 7.500% Senior Secured Notes due 2030, reducing the principal outstanding from $570 million to $494.3 million.

FTRE debt tender offer capital structure senior secured notes financial management

Sentiment note

The company successfully reduced its debt, reinforced its balance sheet strength, and demonstrated disciplined financial management by using cash on hand to fund the tender offer

Negative Nov 15, 2025 • 13:22 UTC GlobeNewswire Inc. • Grabar Law Office

Important Notice to Long-Term Shareholders of Avantor, Inc. (NYSE: AVTR); enCore Energy Corp. (NASDAQ: EU); Fortrea Holdings, Inc. (NASDAQ: FTRE); and Stride, Inc. (NYSE: LRN): Grabar Law Office Investigates Claims on Your Behalf

Law firm Grabar Law Office is investigating potential securities fraud and fiduciary duty breaches for four publicly traded companies, alleging misleading statements and undisclosed material facts that impacted investor interests.

AVTR EU FTRE LRN shareholder investigation securities fraud fiduciary duty class action

Sentiment note

Claims of overestimating revenue, overstating cost savings, and inflating EBITDA targets

Neutral Oct 15, 2025 • 11:00 UTC GlobeNewswire Inc. • Tracy Krumme

Fortrea Announces Date for Third Quarter 2025 Financial Results and Conference Call

Fortrea, a global contract research organization, will release its third quarter 2025 financial results on November 5, 2025, with a conference call scheduled at 8:00 am ET to review the results and conduct a Q&A session.

FTRE financial results earnings call contract research organization clinical development

Sentiment note

The article is a standard financial results announcement without indicating positive or negative performance, presenting routine corporate communication about an upcoming earnings call

Neutral Sep 12, 2025 • 20:15 UTC GlobeNewswire Inc. • Fortrea

Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Fortrea announced granting 75,000 restricted stock units (RSUs) to a newly hired employee, with vesting occurring in three equal annual installments starting September 12, 2026.

FTRE RSUs inducement award stock grant new employee

Sentiment note

The announcement is a standard corporate action of granting stock units to a new employee, which does not inherently suggest positive or negative market implications

Neutral Aug 6, 2025 • 21:21 UTC The Motley Fool • Jesterai

Fortrea (FTRE) Q2 Revenue Jumps 7%

Fortrea Holdings reported Q2 2025 revenue of $710.3 million, beating analyst estimates by 12.5%. Despite positive revenue growth and improved adjusted earnings, the company faced challenges including a significant goodwill impairment and a book-to-bill ratio below target.

FTRE clinical trials contract research pharmaceutical services earnings report goodwill impairment

Sentiment note

Mixed financial performance with revenue growth and improved adjusted earnings, offset by goodwill impairment, reduced cash reserves, and below-target book-to-bill ratio

Neutral Aug 6, 2025 • 10:30 UTC GlobeNewswire Inc. • Fortrea Holdings Inc.

Fortrea Reports Second Quarter 2025 Results

Fortrea reported Q2 2025 revenues of $710.3 million, with a GAAP net loss of $374.9 million, primarily due to a non-cash goodwill impairment charge. The company raised its 2025 revenue guidance and welcomed new CEO Anshul Thakral.

FTRE contract research organization clinical development financial results goodwill impairment CEO transition

Sentiment note

Mixed financial performance with revenue growth and raised guidance, offset by significant goodwill impairment and net loss, indicating ongoing business challenges and restructuring

Positive Aug 5, 2025 • 22:00 UTC GlobeNewswire Inc. • Fortrea

Fortrea Appoints Tracy Krumme as Senior Vice President, Investor Relations

Fortrea has appointed Tracy Krumme as senior vice president of investor relations, succeeding Hima Inguva. Krumme brings over three decades of experience in investor relations and capital markets across life sciences and healthcare sectors.

FTRE TMO investor relations CRO leadership change capital markets

Sentiment note

Company is bringing in an experienced executive with deep industry knowledge, signaling strategic growth and leadership continuity

Negative Jul 31, 2025 • 00:10 UTC GlobeNewswire Inc. • Bragar Eagel & Squire, P.C.

FORTREA URGENT DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors in Fortrea Holdings (FTRE) of The August 1st Deadline and Urges Investors to Contact The Firm

A class action lawsuit has been filed against Fortrea Holdings, alleging the company overstated revenue projections and business prospects following its spin-off from Labcorp in 2023, resulting in significant stock price decline.

FTRE LH class action lawsuit securities spin-off financial performance

Sentiment note

Stock price dropped 25.05% after revealing revenue and profitability were lower than expected, with potential ongoing financial performance challenges in 2025

Negative Jul 29, 2025 • 16:00 UTC GlobeNewswire Inc. • Law Offices Of Howard G. Smith

DEADLINE ALERT for FTRE, VSTS: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions

Law firm alerts investors about potential securities fraud class action lawsuits for Fortrea Holdings and Vestis Corporation, with upcoming lead plaintiff deadlines in August 2025.

FTRE VSTS securities fraud class action investor lawsuit financial misconduct

Sentiment note

Allegations of overstating revenue, cost savings, and business prospects, which potentially misled investors about the company's financial performance